Immunovant, Inc. (IMVT)
37.36
-0.74
(-1.94%)
USD |
NASDAQ |
Sep 11, 16:00
37.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunovant Price : 37.36 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 38.62 | 38.93 | 37.19 | 37.36 | 1.032M |
| Sep 10, 2026 | 38.18 | 38.30 | 37.52 | 38.10 | 1.083M |
| Sep 09, 2026 | 39.11 | 39.73 | 38.67 | 38.75 | 1.024M |
| Sep 08, 2026 | 38.59 | 40.56 | 38.34 | 39.57 | 1.514M |
| Sep 04, 2026 | 39.44 | 39.73 | 38.73 | 39.25 | 765743.0 |
| Sep 03, 2026 | 39.48 | 39.48 | 38.64 | 39.12 | 1.235M |
| Sep 02, 2026 | 40.15 | 40.96 | 38.61 | 39.49 | 1.331M |
| Sep 01, 2026 | 40.60 | 41.37 | 39.20 | 39.90 | 1.585M |
| Aug 31, 2026 | 40.96 | 41.28 | 39.91 | 40.82 | 1.392M |
| Aug 28, 2026 | 43.27 | 43.38 | 41.08 | 41.20 | 1.083M |
| Aug 27, 2026 | 43.60 | 43.94 | 43.14 | 43.82 | 868536.0 |
| Aug 26, 2026 | 43.54 | 44.21 | 42.64 | 43.89 | 852458.0 |
| Aug 25, 2026 | 43.79 | 44.50 | 43.27 | 43.50 | 1.347M |
| Aug 24, 2026 | 44.00 | 44.04 | 43.20 | 43.32 | 1.189M |
| Aug 21, 2026 | 44.85 | 45.12 | 44.08 | 44.37 | 846595.0 |
| Aug 20, 2026 | 44.37 | 44.69 | 43.42 | 44.35 | 954414.0 |
| Aug 19, 2026 | 45.26 | 45.42 | 44.11 | 44.96 | 1.274M |
| Aug 18, 2026 | 42.95 | 44.38 | 42.64 | 44.30 | 1.544M |
| Aug 17, 2026 | 41.72 | 43.89 | 41.46 | 43.71 | 1.217M |
| Aug 14, 2026 | 42.16 | 42.16 | 40.82 | 41.82 | 722489.0 |
| Aug 13, 2026 | 42.92 | 42.92 | 41.63 | 41.82 | 1.361M |
| Aug 12, 2026 | 40.92 | 42.62 | 40.70 | 42.60 | 2.002M |
| Aug 11, 2026 | 39.66 | 40.93 | 38.98 | 40.93 | 1.139M |
| Aug 10, 2026 | 39.95 | 40.00 | 39.13 | 39.89 | 1.194M |
| Aug 07, 2026 | 39.86 | 40.33 | 38.95 | 39.95 | 906297.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 143.97 |
| Altimmune, Inc. | 3.27 |
| TG Therapeutics, Inc. | 53.89 |
| Dianthus Therapeutics, Inc. | 106.20 |
| First Tracks Biotherapeutics, Inc. | 36.44 |
Price Related Metrics
| Price to Book Value | 10.48 |
| Earnings Yield | -7.52% |
| Market Cap | 7.706B |